Adirondack Trust CO Amgen Inc Transaction History

Adirondack Trust CO

$271 Million
Q2 2025

A detailed history of Adirondack Trust CO transactions in Amgen Inc stock. As of the latest transaction made, Adirondack Trust CO holds 2,874 shares of AMGN stock, worth $866,137. This represents 0.3% of its overall portfolio holdings.

Number of Shares

2,874

Previous 2,916 1.44%

Holding current value

$866,137

Previous $908,000 11.67%

% of portfolio

0.3%

Previous 0.36%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 11, 2025	SELL	$262.28 - $309.85 $11,015 - $13,013	-42 Reduced 1.44%	2,874 $802,000
Q1 2025 Apr 03, 2025	SELL	$258.59 - $327.36 $16,032 - $20,296	-62 Reduced 2.08%	2,916 $908,000
Q4 2024 Jan 17, 2025	BUY	$258.78 - $328.31 $22,772 - $28,891	88 Added 3.04%	2,978 $776,000
Q3 2024 Oct 08, 2024	BUY	$309.38 - $337.38 $9,590 - $10,458	31 Added 1.08%	2,890 $931,000
Q2 2024 Jul 09, 2024	SELL	$262.75 - $319.31 $2,627 - $3,193	-10 Reduced 0.35%	2,859 $893,000
Q1 2024 Apr 09, 2024	BUY	$268.87 - $324.56 $5,646 - $6,815	21 Added 0.74%	2,869 $815,000
Q4 2023 Mar 29, 2024	BUY	$255.7 - $288.46 $8,949 - $10,096	35 Added 1.24%	2,848 $820,000
Q3 2023 Oct 31, 2023	BUY	$218.65 - $271.46 $26,893 - $33,389	123 Added 4.57%	2,813 $756,000
Q2 2023 Aug 09, 2023	SELL	$214.27 - $253.37 $2,785 - $3,293	-13 Reduced 0.48%	2,690 $597,000
Q1 2023 Apr 28, 2023	BUY	$225.79 - $275.2 $5,870 - $7,155	26 Added 0.97%	2,703 $653,000
Q3 2022 Oct 13, 2022	BUY	$224.46 - $253.15 $8,753 - $9,872	39 Added 1.48%	2,677 $603,000
Q2 2022 Jul 06, 2022	BUY	$230.71 - $256.74 $24,455 - $27,214	106 Added 4.19%	2,638 $642,000
Q1 2022 Apr 05, 2022	BUY	$219.27 - $242.57 $169,714 - $187,749	774 Added 44.03%	2,532 $612,000
Q4 2021 Jan 13, 2022	BUY	$198.88 - $227.6 $4,972 - $5,690	25 Added 1.44%	1,758 $395,000
Q3 2021 Nov 16, 2021	BUY	$212.27 - $248.7 $5,519 - $6,466	26 Added 1.52%	1,733 $359,000
Q1 2021 Apr 16, 2021	BUY	$221.91 - $258.6 $99,859 - $116,370	450 Added 35.8%	1,707 $425,000
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $1,081 - $1,288	-5 Reduced 0.4%	1,257 $303,000
Q1 2020 Apr 23, 2020	SELL	$182.24 - $241.7 $189,529 - $251,368	-1,040 Reduced 45.18%	1,262 $256,000
Q4 2019 Feb 11, 2020	BUY	$189.21 - $243.2 $200,562 - $257,792	1,060 Added 85.35%	2,302 $497,000
Q3 2019 Oct 09, 2019	BUY	$174.11 - $208.62 $4,178 - $5,006	24 Added 1.97%	1,242 $240,000
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $28,939 - $32,620	-160 Reduced 11.61%	1,218 $218,000
Q3 2018 Oct 22, 2018	BUY	$185.29 - $208.89 $3,149 - $3,551	17 Added 1.25%	1,378 $286,000
Q1 2018 May 03, 2018	SELL	$169.43 - $198.0 $9,149 - $10,692	-54 Reduced 3.82%	1,361 $237,000
Q3 2017 Oct 12, 2017	BUY	$167.29 - $191.0 $236,715 - $270,265	1,415	1,415 $264,000

Others Institutions Holding AMGN

# of Institutions

3,284

Shares Held

426M

Call Options Held

7.45M

Put Options Held

7.46M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $161B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adirondack Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Adirondack Trust CO with notifications on news.

Account

Adirondack Trust CO Amgen Inc Transaction History